summary grapefruit is a popular tasty and nutritive fruit enjoyed globallybiomedical evidence in the last 10 years has however shown that consumption of grapefruit or its juice is associated with drug interactions which in some cases have been fatalgrapefruitinduced drug interactions are unique in that the cytochrome p450 enzyme cyp3a4 which metabolises over 60 of commonly prescribed drugs as well as other drug transporter proteins such as pglycoprotein and organic cation transporter proteins which are all expressed in the intestines are involvedhowever the extent to which grapefruitdrug interactions impact on clinical settings has not been fully determined probably because many cases are not reportedit has recently emerged that grapefruit by virtue of its rich flavonoid content is beneficial in the management of degenerative diseases such as diabetes and cardiovascular disordersthis potentially explosive subject is reviewed here